Nanomedicine Delivers Promising Treatments for Rheumatoid Arthritis

References

• Bian Z , GuoY , HaB , ZenK , LiuY . Regulation of the inflammatory response: enhancing neutrophil infiltration under chronic inflammatory conditions . J. Immunol.188 ( 2 ), 844 – 853 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Fadok VA , BrattonDL , KonowalA , FreedPW , WestcottJY , HensonPM . Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF . J. Clin. Invest.101 ( 4 ), 890 – 898 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Abe R , DonnellySC , PengT , BucalaR , MetzCN . Peripheral blood fibrocytes: differentiation pathway and migration to wound sites . J. Immunol.166 ( 12 ), 7556 – 7562 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Kumar V , AbbasAK , FaustoN , MitchellRN . Robbins Basic Pathology (8th Edition) . Saunders/Elsevier Health Sciences , PA, USA , 31 – 58 ( 2007 ).
   Google Scholar
• Fichtner-Feigl S , StroberW , GeisslerEK , SchlittHJ . Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis . Mucosal Immunol.1 , S24 – S27 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kennedy A , DeleoF . Neutrophil apoptosis and the resolution of infection . Immunol. Res.43 ( 1–3 ), 25 – 61 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Reddy NM , KleebergerSR , KenslerTW , YamamotoM , HassounPM , ReddySP . Disruption of Nrf2 Impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice . J. Immunol.182 ( 11 ), 7264 – 7271 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Mcinnes IB , SchettG . The pathogenesis of rheumatoid arthritis . N. Engl. J. Med.365 ( 23 ), 2205 – 2219 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Sartor RB . Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis . Nat. Clin. Pract. Gastroenterol. Hepatol.3 , 390 – 407 ( 2006 ).
   PubMedGoogle Scholar
• Tuder RM , PetracheI . Pathogenesis of chronic obstructive pulmonary disease . J. Clin. Invest.122 ( 8 ), 2749 – 2755 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Scott DL , WolfeF , HuizingaTWJ . Rheumatoid arthritis . Lancet376 ( 9746 ), 1094 – 1108 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Cooper NJ . Economic burden of rheumatoid arthritis: a systematic review . Rheumatology (Oxford)39 ( 1 ), 28 – 33 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Park KT , BassD . Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review . Inflammat. Bowel Dis.17 ( 7 ), 1603 – 1609 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lajas C , AbasoloL , BellajdelBet al. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study . Arthritis Care Res.49 ( 1 ), 64 – 70 ( 2003 ).
   Web of Science ®Google Scholar
• Prenzler A , BokemeyerB , SchulenburgJM , MittendorfT . Health care costs and their predictors of inflammatory bowel diseases in Germany . Eur. J. Health Econ.12 ( 3 ), 273 – 283 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Jacobs P , BissonnetteR , GuentherLC . Socioeconomic burden of immune-mediated inflammatory diseases – focusing on work productivity and disability . J. Rheumatol.88 , 55 – 61 ( 2011 ).
   Google Scholar
• Birnbaum H , PikeC , KaufmanR , MaynchenkoM , KidoleziY , CifaldiM . Societal cost of rheumatoid arthritis patients in the US . Curr. Med. Res. Opin.26 ( 1 ), 77 – 90 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Teunou E , PonceletD . Batch and continuous fluid bed coating – review and state of the art . J. Food Eng.53 ( 4 ), 325 – 340 ( 2002 ).
   Web of Science ®Google Scholar
• Smolen JS , RedlichK . The Autoimmune Diseases (5th Edition) . RoseNR , MackayIR ( Eds ). Elsevier/Academic Press , Amsterdam, The Netherlands , 511 – 523 ( 2006 ).
   Google Scholar
• Šenolt L , VencovskýJ , PavelkaK , OspeltC , GayS . Prospective new biological therapies for rheumatoid arthritis . Autoimmun. Rev.9 ( 2 ), 102 – 107 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Bayry J , KaveriSV , KazatchkineMD , Lacroix-DesmazesS . Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action . Nat. Clin. Pract. Rheumatol.3 ( 5 ), 262 – 272 ( 2007 ).
   PubMedGoogle Scholar
• Santamaria P . Cytokines and Chemokines in Autoimmune Disease: An Overview . Landes Bioscience , TX, USA ( 2003 ).
   Google Scholar
• Morel J , BerenbaumF . Signal transduction pathways: new targets for treating rheumatoid arthritis . Joint Bone Spine71 ( 6 ), 503 – 510 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Cohen SB , ChengT-T , ChindaloreVet al. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis . Arthritis Rheumat.60 ( 2 ), 335 – 344 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Weinblatt ME , KavanaughA , Burgos-VargasRet al. Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial . Arthritis Rheumat.58 ( 11 ), 3309 – 3318 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Duncan R , GasparR . Nanomedicine(s) under the microscope . Mol. Pharm.8 ( 6 ), 2101 – 2141 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Nitsche JM , ChangH-C , WeberPA , NicholsonBJ . A transient diffusion model yields unitary gap junctional permeabilities from images of cell-to-cell fluorescent dye transfer between xenopus oocytes . Biophys. J.86 ( 4 ), 2058 – 2077 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Weber PA , ChangH-C , SpaethKE , NitscheJM , NicholsonBJ . The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities . Biophys. J.87 ( 2 ), 958 – 973 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Dhein S . Gap junction channels in the cardiovascular system: pharmacological and physiological modulation . Trends Pharmacol. Sci.19 ( 6 ), 229 – 241 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Revel JP , KarnovskyMJ . Hexagonal array of subunits in intercellular junctions of the mouse heart and liver . J. Cell Biol.33 ( 3 ), C7 – C12 ( 1967 ).
   PubMed Web of Science ®Google Scholar
• Maeda H . The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting . Adv. Enzyme Regul.41 ( 1 ), 189 – 207 ( 2001 ).
   PubMedGoogle Scholar
• Yuan F , DellianM , FukumuraDet al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size . Cancer Res.55 ( 17 ), 3752 – 3756 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Castro E , KumarA . Nanomedicine in Drug Delivery . KumarA , MansourHM , FriedmanA , BloughER ( Eds ). CRC Press/Taylor & Francis Group , FL, USA , 1 – 22 ( 2013 ).
   Google Scholar
• Gupta RB . Nanoparticle Technology for Drug Delivery . GuptaRB , KompellaUB ( Eds ). Taylor & Francis , NY, USA , 1 – 20 ( 2006 ).
   Google Scholar
• Veronese F , MeroA , PasutG . Protein PEGylation, basic science and biological applications . In : PEGylated Protein Drugs: Basic Science and Clinical Applications . VeroneseF ( Ed. ). Birkhäuser Verlag , Basel, Switzerland , 11 – 31 ( 2009 ).
   Google Scholar
• Gabizon AA . PEGylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy . Cancer Invest.19 ( 4 ), 424 – 436 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Maeda H . Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects . Bioconjug. Chem.21 ( 5 ), 797 – 802 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Maeda H . The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect . Cancer Sci.104 ( 7 ), 779 – 789 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ochoa CD , StevensT . Studies on the cell biology of interendothelial cell gaps . Am. J. Physiol.302 ( 3 ), L275 – L286 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Szekanecz Z , KochA . Chemokines and cytokines in inflammatory angiogenesis . In : Angiogenesis in Inflammation: Mechanisms and Clinical Correlates . SeedM , WalshD ( Eds ). Birkhäuser Verlag , Basel, Switzerland , 83 – 98 ( 2008 ).
   Google Scholar
• Sans M , PanésJ , ArditeEet al. VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis . Gastroenterology116 ( 4 ), 874 – 883 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Koo O , RubinsteinI , ÖnyükselH . Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis . Pharm. Res.28 ( 4 ), 776 – 787 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Martinez-Lostao L , Garcia-AlvarezF , BasanezGet al. Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis . Arthritis Rheumat.62 ( 8 ), 2272 – 2282 ( 2010 ).
   PubMedGoogle Scholar
• ClinicalTrials.gov . www.clinicaltrials.gov .
   Google Scholar
• Chiong HS , YongYK , AhmadZet al. Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages . Int. J. Nanomedicine8 , 1245 – 1255 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Turk CTS , OzUC , SerimTM , HascicekC . Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments . AAPS PharmSciTech15 ( 1 ), 161 – 176 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• James LRA , XuZ-Q , SluyterRet al. An investigation into the interactions of gold nanoparticles and anti-arthritic drugs with macrophages, and their reactivity towards thioredoxin reductase . J. Inorg. Biochem.142 ( 0 ), 28 – 38 ( 2015 ).
   PubMedGoogle Scholar
• Hofkens W , GreversLC , WalgreenBet al. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis . J. Control. Release152 ( 3 ), 363 – 369 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hofkens W , StormG , Van Den BergWB , Van LentPL . Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis . Int. J. Pharm.416 ( 2 ), 486 – 492 ( 2011 ).
   PubMedGoogle Scholar
• Hofkens W , Van Den HovenJM , PesmanGJet al. Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide . Int. J. Pharm.416 ( 2 ), 493 – 498 ( 2011 ).
   PubMedGoogle Scholar
• Hofkens W , SchelbergenR , StormG , Van Den BergWB , Van LentPL . Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation . PLoS ONE8 ( 2 ), e54016 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Metselaar JM , Van Den BergWB , HolthuysenAE , WaubenMH , StormG , Van LentPL . Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis . Ann. Rheumat. Dis.63 ( 4 ), 348 – 353 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Ulmansky R , TurjemanK , BaruMet al. Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines . J. Control. Release160 ( 2 ), 299 – 305 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Avnir Y , UlmanskyR , WassermanVet al. Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis . Arthritis Rheumat.58 ( 1 ), 119 – 129 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Hwang J , RodgersK , OliverJC , SchluepT . Alpha-methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy . Int. J. Nanomedicine3 ( 3 ), 359 – 371 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Ishihara T , KubotaT , ChoiT , HigakiM . Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate . J. Pharm. Exp. Ther.329 ( 2 ), 412 – 417 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Anderson R , FranchA , CastellMet al. Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis . Arthritis Res. Ther.12 ( 4 ), R147 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Rauchhaus U , SchwaigerFW , PanznerS . Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatment . Arthritis Res. Ther.11 ( 6 ), R190 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Koning GA , SchiffelersRM , WaubenMHet al. Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis . Arthritis Rheumat.54 ( 4 ), 1198 – 1208 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Quan L , ZhangY , CrielaardBJet al. Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes . ACS Nano8 ( 1 ), 458 – 466 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bartneck M , PetersFM , WarzechaKTet al. Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages . Nanomedicine10 ( 6 ), 1209 – 1220 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Thomas TP , GoonewardenaSN , MajorosIJet al. Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis . Arthritis Rheumat.63 ( 9 ), 2671 – 2680 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Mello SB , TavaresER , BulgarelliA , BonfaE , MaranhaoRC . Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis . Int. J. Nanomedicine8 , 443 – 449 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Moura CC , SegundoMA , NevesJD , ReisS , SarmentoB . Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application . Int. J. Nanomedicine9 , 4911 – 4922 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Abolmaali SS , TamaddonA , YousefiG , JavidniaK , DinarvandR . Sequential optimization of methotrexate encapsulation in micellar nano-networks of polyethyleneimine ionomer containing redox-sensitive cross-links . Int. J. Nanomedicine9 , 2833 – 2848 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wahba SMR , DarwishAS , ShehataIH , Abd ElhalemSS . Sugarcane bagasse lignin, and silica gel and magneto-silica as drug vehicles for development of innocuous methotrexate drug against rheumatoid arthritis disease in albino rats . Mat. Sci. Eng. C48 , 599 – 610 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Wilson DR , ZhangN , SilversAL , ForstnerMB , BaderRA . Synthesis and evaluation of cyclosporine A-loaded polysialic acid-polycaprolactone micelles for rheumatoid arthritis . Eur. J. Pharm. Sci.51 , 146 – 156 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kim YJ , ChaeSY , JinCHet al. Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis . Biomaterials31 ( 34 ), 9057 – 9064 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Chuan YP , ZengBY , O’SullivanB , ThomasR , MiddelbergAP . Co-delivery of antigen and a lipophilic anti-inflammatory drug to cells via a tailorable nanocarrier emulsion . J. Colloid Interface Sci.368 ( 1 ), 616 – 624 ( 2012 ).
   PubMedGoogle Scholar
• Zhou HF , YanH , SenpanAet al. Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles . Biomaterials33 ( 33 ), 8632 – 8640 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Heo R , ParkJ-S , JangHJet al. Hyaluronan nanoparticles bearing γ-secretase inhibitor: in vivo therapeutic effects on rheumatoid arthritis . J. Control. Release192 , 295 – 300 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mease PJ , WeiN , FudmanEJet al. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a Phase 1/2 study . J. Rheumatol.37 ( 4 ), 692 – 703 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Foged C , NielsenHM , FrokjaerS . Liposomes for phospholipase A2 triggered siRNA release: preparation and in vitro test . Int. J. Pharm.331 ( 2 ), 160 – 166 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Howard KA , PaludanSR , BehlkeMA , BesenbacherF , DeleuranB , KjemsJ . Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model . Mol. Ther.17 ( 1 ), 162 – 168 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Komano Y , YagiN , OnoueI , KanekoK , MiyasakaN , NankiT . Arthritic joint-targeting small interfering RNA-encapsulated liposome: implication for treatment strategy for rheumatoid arthritis . J. Pharm. Exp. Ther.340 ( 1 ), 109 – 113 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Khoury M , Louis-PlenceP , EscriouVet al. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis . Arthritis Rheumat.54 ( 6 ), 1867 – 1877 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Te Boekhorst BCM , JensenLB , ColomboSet al. MRI-assessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model . J. Control. Release161 ( 3 ), 772 – 780 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Scheinman RI , TrivediR , VermillionS , KompellaUB . Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model . Nanomedicine6 ( 10 ), 1669 – 1682 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhang T , BaiX , MaoX . Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritis . PLoS ONE8 ( 11 ), e78619 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Fernandes JC , WangH , JreyssatyCet al. Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis . Mol. Ther.16 ( 7 ), 1243 – 1251 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Jung Y-S , ParkW , NaK . Temperature-modulated noncovalent interaction controllable complex for the long-term delivery of etanercept to treat rheumatoid arthritis . J. Control. Release171 ( 2 ), 143 – 151 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sethi V , RubinsteinI , KuzmisA , KastrissiosH , ArtwohlJ , OnyukselH . Novel, Biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis . Mol. Pharm.10 ( 2 ), 728 – 738 ( 2012 ).
   Google Scholar
• Nakashima-Matsushita N , HommaT , YuSet al. Selective expression of folate receptor β and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis . Arthritis Rheumat.42 ( 8 ), 1609 – 1616 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Yusuf-Makagiansar H , AndersonME , YakovlevaTV , MurrayJS , SiahaanTJ . Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases . Medicinal Res. Rev.22 ( 2 ), 146 – 167 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Huang M-T , MasonJC , BirdseyGMet al. Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis . Blood106 ( 5 ), 1636 – 1643 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Onat D , BrillonD , ColomboP , SchmidtA . Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis . Curr. Diab. Rep.11 ( 3 ), 193 – 202 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Delgado M , AbadC , MartinezCet al. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases . J. Mol. Med.80 ( 1 ), 16 – 24 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Gaddy D , RobbinsP . Current status of gene therapy for rheumatoid arthritis . Curr. Rheumatol. Rep.10 ( 5 ), 398 – 404 ( 2008 ).
   PubMedGoogle Scholar
• Dizaj SM , JafariS , KhosroushahiAY . A sight on the current nanoparticle-based gene delivery vectors . Nanoscale Res. Lett.9 ( 1 ), 252 – 252 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Liu C , ZhangN . Nanoparticles in gene therapy: principles, prospects, and challenges . In : Progress in Molecular Biology and Translational Science . AntonioV ( Ed. ). Academic Press , CA, USA , 509 – 562 ( 2011 ).
   Google Scholar
• Danhier F , AnsorenaE , SilvaJM , CocoR , Le BretonA , PréatV . PLGA-based nanoparticles: an overview of biomedical applications . J. Control. Release161 ( 2 ), 505 – 522 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Yagi N , ManabeI , TottoriTet al. A Nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo . Cancer Res.69 ( 16 ), 6531 – 6538 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Gura T . How TRAIL kills cancer cells, but not normal cells . Science277 ( 5327 ), 768 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Siddik ZH . apoptosis in cancer: mechanisms, deregulation, and therapeutic targeting . In : Cancer Drug Design and Discovery (2nd Edition) . NeidleS ( Ed. ). Academic Press , CA, USA , 357 – 390 ( 2014 ).
   Google Scholar
• Van Roosmalen IaM , QuaxWJ , KruytFaE . Two death-inducing human TRAIL receptors to target in cancer: similar or distinct regulation and function?Biochem. Pharmacol.91 ( 4 ), 447 – 456 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mellier G , HuangS , ShenoyK , PervaizS . TRAILing death in cancer . Mol. Aspects Med.31 ( 1 ), 93 – 112 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Duiker EW , MomCH , De JongSet al. The clinical trail of TRAIL . Eur. J. Cancer42 ( 14 ), 2233 – 2240 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Falschlehner C , SchaeferU , WalczakH . Following TRAIL’s path in the immune system . Immunology127 ( 2 ), 145 – 154 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Tarrus M , SlootA , TemmingKet al. RGD-avidin–biotin pretargeting to αvβ3 integrin enhances the proapoptotic activity of TNFα related apoptosis inducing ligand (TRAIL) . Apoptosis13 ( 2 ), 225 – 235 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Tinkle S , McneilSE , MühlebachSet al. Nanomedicines: addressing the scientific and regulatory gap . Ann. NY Acad. Sci.1313 ( 1 ), 35 – 56 ( 2014 ).
   PubMed Web of Science ®Google Scholar